Last Price$236.80.4%
Market Cap$38.4B
16.2%
Peers median - 6.4%
39.3%
Peers median - 11.1%
1.3%
Peers median - 8.6%
38.8%
Peers median - 3.7%
Competing with VEEV
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Quality rating | Intrinsic value | 1Y Return | Revenue | Free Cash Flow | Revenue growth | FCF margin | Gross margin | ROIC | Total Debt to Equity |
$38.4B | 7.7 | $142.7 39.7% overvalued | 2.1% | $2,746.6M | $1,078.5M | 16.2% | 39.3% | 74.5% | 38.8% | 1.3% | |
$37.2B | 5.7 | $146.3 79.5% undervalued | (10.5%) | $19.7B | $1,550.0M | 0.6% | 7.9% | 41.7% | 10.9% | 17.4% | |
$11.8B | 8.2 | $23.0 63.5% overvalued | 124.8% | $550.2M | $238.8M | 17.5% | 43.4% | 90.2% | 69.3% | 1.3% | |
$7,373.5M | 6.5 | $50.4 40.6% overvalued | 3.3% | $1,199.8M | ($165.6M) | 20.0% | (13.8%) | 60.1% | 4.9% | 52.4% | |
$6,040.3M | 6.0 | $14.2 0.7% overvalued | 33.2% | $2,463.7M | $186.4M | 11.4% | 7.6% | 19.2% | 2.5% | 83.1% | |
$2,804.0M | 5.7 | $2,574.6 10,930.9% undervalued | 16.9% | $1,736.4M | $109.3M | 4.7% | 6.3% | 10.2% | 0.0% | 0.0% | |
$1,875.8M | 6.6 | $38.4 75.7% undervalued | (41.0%) | $1,167.2M | $173.7M | 7.2% | 14.9% | 21.7% | 20.1% | 4.6% | |
$1,770.7M | 6.4 | $8.3 80.0% undervalued | (31.3%) | $792.3M | $113.5M | 5.6% | 14.3% | 89.8% | 10.1% | 7.8% | |
$1,757.9M | 5.7 | $57.2 208.6% undervalued | (11.2%) | $1,181.3M | $368.5M | (10.2%) | 31.2% | 66.5% | (2.6%) | 9.4% | |
$1,721.0M | 5.7 | $6.4 40.7% overvalued | (39.1%) | $385.1M | $73.4M | 8.7% | 19.1% | 53.1% | 0.8% | 2.9% | |
$1,584.2M | 6.1 | $11.3 47.9% overvalued | (20.8%) | $207.5M | ($164.7M) | (4.2%) | (79.3%) | 63.6% | (75.0%) | 28.0% |
Compare VEEV Valuation Multiples with Peers
LTM
NTM
1Y Forward
2Y Forward
EV/Revenue
General
Valuation Multiple
Financial metrics
Company name
EV/Revenue
Revenue growth
EBITDA margin
Net Income margin
Veeva Systems Inc.VEEV
12.2x
16.2%
34.9%
26.0%
Median Peer Set
2.6x
6.4%
0.0%
3.4%
Certara, Inc.CERT
4.1x
8.7%
(78.5%)
(3.1%)
Doximity, Inc.DOCS
19.9x
13.5%
34.5%
31.0%
GoodRx Holdings, Inc.GDRX
1.7x
5.6%
N/A
2.1%
GE HealthCare Technologies Inc.GEHC
1.8x
0.6%
43.8%
10.1%
HealthEquity, Inc.HQY
6.8x
16.0%
N/A
5.6%
Progyny, Inc.PGNY
1.4x
7.2%
(9.2%)
4.7%
Premier, Inc.PINC
1.6x
0.8%
(28.6%)
8.9%
Privia Health Group, Inc.PRVA
(281.2x)
4.7%
(40.0%)
0.8%
R1 RCM Inc.RCM
3.3x
24.8%
N/A
0.1%
Schrödinger, Inc.SDGR
6.5x
(4.2%)
N/A
(90.2%)
Compare VEEV Valuation Multiples Dynamics with Peers
Crunching data... Almost there!
FAQ
1. How does Veeva Systems Inc. (VEEV) revenue growth compare to peers and the industry?
Veeva Systems Inc. (VEEV) revenue growth is 16.2%, compared to the peers' median of 6.4%.
2. How does Veeva Systems Inc. (VEEV) Free Cash Flow (FCF) margin compare to peers and the industry?
Veeva Systems Inc. (VEEV) FCF margin is 39.3%, compared to the peers' median of 11.1%.
3. How does Veeva Systems Inc. (VEEV) Total Debt to Equity ratio compare to peers and the industry?
Veeva Systems Inc. (VEEV) Total Debt to Equity ratio is 1.3%, compared to the peers' median of 8.6%.
4. How does Veeva Systems Inc. (VEEV) ROIC (Return on Invested Capital) compare to peers and the industry?
Veeva Systems Inc. (VEEV) ROIC is 38.8%, compared to the peers' median of 3.7%.